164 related articles for article (PubMed ID: 27539099)
1. Serum nesfatin-1 levels in patients with different glucose tolerance levels.
Algul S; Ozkan Y; Ozcelik O
Physiol Res; 2016 Dec; 65(6):979-985. PubMed ID: 27539099
[TBL] [Abstract][Full Text] [Related]
2. Increased plasma levels of nesfatin-1 in patients with newly diagnosed type 2 diabetes mellitus.
Zhang Z; Li L; Yang M; Liu H; Boden G; Yang G
Exp Clin Endocrinol Diabetes; 2012 Feb; 120(2):91-5. PubMed ID: 22020667
[TBL] [Abstract][Full Text] [Related]
3. Cross-sectional correlates of nesfatin and lipopolysaccharide binding protein in metabolic syndrome patients with and without prediabetes.
Al-Qudah SA; Kasabri V; Saleh MI; Suyagh M; AlAlawi S; Yasin N
Horm Mol Biol Clin Investig; 2018 Sep; 36(3):. PubMed ID: 30205641
[TBL] [Abstract][Full Text] [Related]
4. [Insulin sensitivity and beta function in the first-degree relatives of type 2 diabetic patients].
Han XY; Ji LN; Zhou XH
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1777-80. PubMed ID: 15631772
[TBL] [Abstract][Full Text] [Related]
5. Decreased plasma nesfatin-1 level is related to the thyroid dysfunction in patients with type 2 diabetes mellitus.
Liu F; Yang Q; Gao N; Liu F; Chen S
J Diabetes Res; 2014; 2014():128014. PubMed ID: 24995340
[TBL] [Abstract][Full Text] [Related]
6. Cord blood nesfatin-1 and apelin-36 levels in gestational diabetes mellitus.
Aslan M; Celik O; Celik N; Turkcuoglu I; Yilmaz E; Karaer A; Simsek Y; Celik E; Aydin S
Endocrine; 2012 Jun; 41(3):424-9. PubMed ID: 22203468
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of nesfatin-1 are increased in gestational diabetes mellitus.
Zhang Y; Lu JH; Zheng SY; Yan JH; Chen L; Liu X; Wu WZ; Wang F
Gynecol Endocrinol; 2017 Aug; 33(8):621-624. PubMed ID: 28361552
[TBL] [Abstract][Full Text] [Related]
8. Saxagliptin Upregulates Nesfatin-1 Secretion and Ameliorates Insulin Resistance and Metabolic Profiles in Type 2 Diabetes Mellitus.
Chen K; Zhuo T; Wang J; Mei Q
Metab Syndr Relat Disord; 2018 Sep; 16(7):336-341. PubMed ID: 29912623
[TBL] [Abstract][Full Text] [Related]
9. The relation of serum nesfatin-1 level with metabolic and clinical parameters in obese and healthy children.
Abaci A; Catli G; Anik A; Kume T; Bober E
Pediatr Diabetes; 2013 May; 14(3):189-95. PubMed ID: 23346951
[TBL] [Abstract][Full Text] [Related]
10. Serum nesfatin-1 and galanin concentrations in the adult with metabolic syndrome. Relationships to insulin resistance and obesity.
Alotibi MN; Alnoury AM; Alhozali AM
Saudi Med J; 2019 Jan; 40(1):19-25. PubMed ID: 30617376
[TBL] [Abstract][Full Text] [Related]
11. The relation of serum nesfatin-1 level with anthropometric and metabolic parameters in children and adolescents: A prospective observational study.
Kim SH; Ahn MB; Cho WK; Cho KS; Jung MH; Suh BK
Medicine (Baltimore); 2019 May; 98(19):e15460. PubMed ID: 31083178
[TBL] [Abstract][Full Text] [Related]
12. Serum nesfatin-1 levels are decreased in pregnant women newly diagnosed with gestational diabetes.
Ademoglu EN; Gorar S; Keskin M; Carlioglu A; Ucler R; Erdamar H; Culha C; Aral Y
Arch Endocrinol Metab; 2017; 61(5):455-459. PubMed ID: 28977160
[TBL] [Abstract][Full Text] [Related]
13. Thiazolidinediones increase hepatic insulin extraction in African Americans with impaired glucose tolerance and type 2 diabetes mellitus. A pilot study of rosiglitazone.
Osei K; Gaillard T; Schuster D
Metabolism; 2007 Jan; 56(1):24-9. PubMed ID: 17161222
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Insulin Resistance and β-Cell Dysfunction Between the Young and the Elderly in Normal Glucose Tolerance and Prediabetes Population: A Prospective Study.
Chen G; Shi L; Cai L; Lin W; Huang H; Liang J; Li L; Lin L; Tang K; Chen L; Lu J; Bi Y; Wang W; Ning G; Wen J
Horm Metab Res; 2017 Feb; 49(2):135-141. PubMed ID: 27459384
[TBL] [Abstract][Full Text] [Related]
15. Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state.
Tripathy D; Carlsson AL; Lehto M; Isomaa B; Tuomi T; Groop L
Diabetologia; 2000 Dec; 43(12):1476-83. PubMed ID: 11151756
[TBL] [Abstract][Full Text] [Related]
16. Association of traits of metabolic syndrome with glucose abnormalities.
Hoffmann IS; Cubeddu LX
Am J Ther; 2013; 20(4):363-8. PubMed ID: 23591026
[TBL] [Abstract][Full Text] [Related]
17. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
[TBL] [Abstract][Full Text] [Related]
18. Fasting and postprandial levels of a novel anorexigenic peptide nesfatin in childhood obesity.
Anık A; Çatlı G; Abacı A; Küme T; Bober E
J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):623-8. PubMed ID: 24825087
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular risk factors, carotid artery intima media thickness, and HSCRP levels in patients with impaired glucose metabolism.
Karbek B; Cakal E; Cakir E; Bozkurt N; Unsal I; Sahin M; Delibaşi T
Minerva Endocrinol; 2013 Sep; 38(3):297-304. PubMed ID: 24126550
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome in subjects at high risk for type 2 diabetes: the genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study.
Bianchi C; Miccoli R; Bonadonna RC; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Alviggi L; Gnasso A; Consoli A; Cavalot F; Cavallo MG; Leonetti F; Giaccari A; Del Prato S;
Nutr Metab Cardiovasc Dis; 2011 Sep; 21(9):699-705. PubMed ID: 21291660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
